Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Neoplasms 1 Malignant Disease 1

Interventions

Carboplatin 71 Etoposide 63 Topotecan 42 Cisplatin 38 pembrolizumab 30 atezolizumab 26 durvalumab 22 Paclitaxel 16 Nivolumab 14 PM 01183 13 rovalpituzumab tesirine 11 Pemetrexed 11 amrubicin 9 Ipilimumab 9 Injections 9 Irinotecan 8 AMG 757 8 trilaciclib 7 etoposide phosphate 6 EC regimen 6 Drug Therapy 6 Docetaxel 6 Bevacizumab 6 tremelimumab 5 MLN 8237 5 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 olaparib 4 chiauranib 4 budigalimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Small Cell Lung Carcinoma × amuvatinib × Clear all

NCT01357395 2024-08-02

ESCAPE

Astex Pharmaceuticals, Inc.

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡